The effects of ovulation induction on ovarian epithelium dysplasia scores and Ki67 expression: An experimental study on rats

International Journal of Gynecological Cancer

Volumn 15, Issue 5, 2005, Pages 866-871

  Corakci, A ^a   Filiz, S ^a   Caliskan, Eray ^a,b   Dalcik, C ^a   Ozeren, S ^a   Dalcik, H ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Dysplasia score; Epithelium; Ki67 expression; Ovary; Ovulation induction

Indexed keywords

CHORIONIC GONADOTROPIN; GONADOTROPIN; KI 67 ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CORPUS LUTEUM; DRUG EFFECT; DRUG MECHANISM; DYSPLASIA; EPITHELIUM; EPITHELIUM CELL; ESTRUS CYCLE; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVARIECTOMY; OVARY DISEASE; OVARY DYSPLASIA; OVULATION INDUCTION; PRIORITY JOURNAL; RAT; STROMA;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; KI-67 ANTIGEN; OVARIAN DISEASES; OVULATION INDUCTION; RATS; RATS, WISTAR;

EID: 28944439613     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.00149.x     Document Type: Article

References (30)

1. Brinton LA, Melton LJ, Malkasian GD, Bond A, Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol 1989;129:712-22.
2. Whittemore AS, Harris R, Itnyre J. The colloborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: colloborative analysis of 12 US case control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992;136:1184-203.
3. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-6.
4. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996;65:13-8.
5. Shushan A, Laufer N. Fertility drugs and ovarian cancer: what are the practical implications of the ongoing debate? Fertil Steril 2000;74:8-9.
6. Gusberg SB, Deligdisch L. Ovarian dysplasia: a study of identical twins. Cancer 1984;54:1-4.
7. Deligdisch L. Ovarian dysplasia: a review. Int J Gynecol Cancer 1997;7:89-94.
8. Plaxe SC, Deligdisch L, Dottino P, Cohen CJ. Ovarian intraepithelial neoplasia (OIN) demonstrated in patients with stage I ovarian carcinoma. Gynecol Oncol 1990;38:367-72.
9. Deligdisch L, Gil J, Kerner H, Wu HS, Beck D, Gershoni-Baruch R. Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations. Cancer 1999;86:1544-50.
10. van Diest PJ, Brugal G, Baak JPA. Proliferation markers in tumours; interpretation and clinical value. J Clin Pathol 1998;51:716-24.
11. Korkolopoulou P, Vassilopoulos I, Konstantinidou AE et al. The combined evaluation of p27 Kip1 and Ki67 expression provides independent information on overall survival of ovarian carcinoma patients. Gynecol Oncol 2002;85:404-14.
12. Konstantinidou AE, Korkolopoulou P, Vassilopoulos I et al. Reduced retinoblastoma gene protein to Ki67 ratio is an adverse prognostic indicator for ovarian adenocarcinoma patients. Gynecol Oncol 2003;88:369-78.
13. Mukumoto S, Mori K, Ishikawa H. Efficient induction of superovulation in adult rats by PMSG and hCG. Exp Anim 1995;44:111-8.
14. Madugno F. The ovarian cancer and high-risk women symposium presenters. Ovarian cancer and high-risk women: implications for prevention, screening and early detection. Gynecol Oncol 2003;91:15-31.
15. Mori M, Nishida T, Sugiyama T et al. Anthropometric and other risk factors for ovarian cancer in a case control study. Jpn J Cancer Res 1998;89:246-53.
16. Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, Escudero-De Los Rios P, Salmoren-Castro J, Hernandez-Avila M. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico. Cancer Res 1999;59:3658-62.
17. Shu XO, Brinton LA, Gao YT, Yuan JM. Population based case control study of ovarian cancer in Shanghai. Cancer Res 1989;49:3670-4.
18. Franceschi S, La Vecchia C, Booth M et al. Pooled analysis of three European case control studies of ovarian cancer. II. Age at menarche and menopause. Int J Cancer 1991;49:57-60.
19. Fredrickson TN. Ovarian tumors of the hen. Environ Health Perspect 1987;73:35-51.
20. Smith ER, Xu X. Etiology of epithelial ovarian cancer: a cellular mechanism for the role of gonadotropins. Gynecol Oncol 2003;91:1-2.
21. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983;71:717-21.
22. Nieto JJ, Crow J, Sundaresan M et al. Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity. Gynecol Oncol 2001;82:344-9.
23. Harris R, Whittemore AS, Itynre J. The collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case control studies. III. Epithelial tumors of low malignant potential in white women. Am J Epidemiol 1992;136:1204-11.
24. Parazzini F, Negri E, LaVecchia C et al. Treatment for fertility and risk of borderline malignancy. Gynecol Oncol 1998;68:226-8.
25. Shushan A, Paltiel O, Schenker JG. Induction of ovulation and borderline ovarian cancer; the hormonal connection? Eur J Obstet Gynecol Reprod Biol 1999;85:71-1.
26. Darai E, Walker-Combrouze F, Dauge-Geoffroy M et al. Ki67 expression in 35 borderline tumour: relations with clinicopathologic parameters and ploidy. Eur J Obstet Gynecol Reprod Biol 1998;76:175-80.
27. Costa MJ, Walls J, Ames P, Roth LM. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p 53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior. Hum Pathol 1996;27:274-81.
28. Ariyoshi K, Kawauchi S, Kaku T, Nakano H, Tsuneyoshi M. Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases. Histopathology 2000;37:427-36.
29. Garzetti GG, Ciavattini A, Goteri G et al. Ki67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance. Gynecol Oncol 1995;56:169-74.
30. Rosenberg L, Palmer JR, Zauber AG et al. A case control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 1994;139:654-61.